Pharmaceuticals Customs Brokers

Pharmaceutical imports into Australia are regulated primarily by the Therapeutic Goods Administration (TGA), which administers the Therapeutic Goods Act 1989. All therapeutic goods — medicines, medical devices, biologicals, and complementary medicines — must be included in the Australian Register of Therapeutic Goods (ARTG) before they can be imported for supply in Australia. The ARTG registration process involves rigorous assessment of safety, quality, and efficacy.

Customs brokers handling pharmaceutical imports manage the intersection of TGA regulatory requirements with customs clearance processes. The TGA's electronic clearance system interfaces with the ABF's Integrated Cargo System to verify that imported therapeutic goods have valid ARTG registrations. Goods without valid registrations are held at the border. Brokers also handle importation of unregistered therapeutic goods under the Special Access Scheme (SAS), Authorised Prescriber pathway, and clinical trial exemptions — each with specific TGA approval requirements.

Cold chain management is critical for many pharmaceutical imports, particularly biologicals and vaccines that require unbroken temperature control from manufacturer to end user. Your broker coordinates with temperature-controlled transport and storage facilities, ensures goods declaration values account for freight and insurance for cold chain logistics, and manages the documentation chain including manufacturer certificates of analysis, Good Manufacturing Practice (GMP) clearances, and any required batch testing by Australian laboratories.